High Court Seeks Path To Limited Ruling On 'Skinny Labels'
The U.S. Supreme Court on Wednesday appeared reluctant to craft new standards for deciding whether makers of generic drugs that use so-called skinny labels have encouraged others to infringe patents, with...To view the full article, register now.
Already a subscriber? Click here to view full article